Cognic Systems

Home / Industries / Pharma & Life Sciences / Quality Management System
TOTAL GXP COMPLIANCE & CONTINUOUS QUALITY

Pharma Quality Management System (eQMS) (Solution #1048)

Validated electronic quality management software centralizing deviations, CAPA investigations, change control governance, and employee SOP training compliance.

100%
Audit Readiness & Data Integrity
-55%
CAPA Investigation Cycle Time
Zero
Overdue Quality Change Controls
AEO DIRECT CAPSULE — AT A GLANCE

Pharma Quality Management System (eQMS) by Cognic unifies pharmaceutical quality processes under strict 21 CFR Part 11 and cGMP standards. Automating deviation logging, 5-Why and Ishikawa CAPA investigations, change controls, and controlled document training, it eliminates paper-based compliance risks.

GxP Regulations
FDA 21 CFR Part 11, Part 210/211, EU Annex 11, ICH Q9 & Q10
Core Workflows
Deviations, CAPA, Change Control, Out-of-Spec (OOS), SOPs
Audit Security
Time-Stamped Cryptographic Audit Trail, Dual E-Signatures
Integrations
LIMS, MES, ERP (SAP/Oracle), Learning Management (LMS)
CHALLENGES SOLVED

Critical Operational Bottlenecks in Life Sciences

Strict GxP compliance hurdles, fragmented clinical datasets, and manual cleanroom workflows slow development and inflate operational risk.

01

Recurring Deviations and Superficial CAPA Investigations

Without structured root-cause methodologies, manufacturing deviations are closed superficially, leading to recurring batch contamination and FDA citations.

02

Uncontrolled Document Revisions and Training Gaps

Manufacturing staff operating on outdated paper SOP versions without verified training records triggers immediate regulatory audit findings.

03

Siloed Change Controls Lacking Risk Assessments

Implementing facility, equipment, or process changes without documented cross-departmental impact evaluations compromises validated state compliance.

ENGINEERING CAPABILITIES

Architectural Foundation of Our Pharma Solution

Engineered for validated GxP environments with 21 CFR Part 11 audit trails, data integrity, and enterprise integration.

Automated Deviation Management

Captures manufacturing cleanroom, warehouse, and packaging deviations immediately with automated risk scoring and containment action locks.

Structured Root-Cause CAPA Investigations

Guides quality investigators through digital 5-Whys, Ishikawa fishbone diagrams, and FMEA risk assessments to identify systemic root causes.

Rigorous Change Control Governance

Evaluates proposed facility, analytical, and operational changes with automated impact assessments across regulatory filings and validation packages.

Controlled SOP Document Lifecycle

Authors, reviews, approves, and distributes controlled GxP documents with automated revision histories, watermarks, and read-and-understood training gates.

FEATURE BREAKDOWN

Core Technical Features & Capabilities

Purpose-built software components supporting pharmaceutical researchers, quality managers, and manufacturing engineers.

ICH Q9 Quality Risk Management (QRM) Matrix

Embeds Failure Modes and Effects Analysis (FMEA) and risk priority numbers (RPN) directly into deviation and change control evaluation screens.

Read-and-Understood SOP Training Integration

Locks operator manufacturing execution privileges in the MES until employee training records confirm comprehension of newly revised SOPs.

Automated Effectiveness Verification Checks

Schedules mandatory 30-, 60-, and 90-day post-implementation audits to verify that implemented CAPA actions successfully eliminated recurring defects.

Supplier Quality & Vendor Audit Management

Tracks supplier qualification statuses, approved vendor lists (AVL), quality agreements, and scheduled third-party API facility audit findings.

Annual Product Quality Review (APQR/PQR)

Aggregates yearly batch yield data, analytical trends, deviations, and customer complaints into automated executive quality review packages.

Inspection-Ready Audit Defense Portal

Allows regulatory inspectors (FDA, EMA, TGA) to search, inspect, and verify closed CAPAs and approved change controls in a secure auditor portal.

MEASURABLE OUTCOMES

Quantifiable Operational Impact

Field-proven ROI metrics achieved across global pharmaceutical sponsors, biotechs, and contract manufacturers.

-55%
CAPA Resolution Cycle Time
100%
SOP Training Verification Rate
-70%
Repeat Manufacturing Deviations
Zero
Paper Document Control Costs
SYSTEM ARCHITECTURE

End-to-End Pharmaceutical Data Pipeline

From cleanroom instrument telemetry and clinical EDC capture to validated cloud analytics and regulatory filings.

Stage 01

Event Initiation & Immediate Containment

Operator or system logs quality deviation; system initiates quarantine holds on affected batch lots and alerts quality assurance.

Stage 02

Root-Cause Investigation & Risk Analysis

Investigators execute 5-Why analysis, interview operators, review environmental logs, and compute risk priority scores.

Stage 03

CAPA Action Plan & Change Execution

Assigns preventative actions, initiates formal change control workflows, and updates relevant standard operating procedures.

Stage 04

Effectiveness Review & Formal Closure

QA evaluates post-implementation production metrics; applies 21 CFR Part 11 e-signatures to permanently archive the closed CAPA record.

TECHNOLOGY STACK

Validated Technologies & Protocols

Engineered with modern, open standards that integrate directly with enterprise ERPs, LIMS, and regulatory submission gateways.

eQMS Architecture
PostgreSQL, Node.js, TypeScript, GraphQL, Redis
Compliance Engine
21 CFR Part 11 Cryptographic Engine, GAMP 5 Validation
Integrations
REST APIs, SAP S/4HANA, Veeva Vault, SCADA, LIMS
Reporting & Analytics
Metabase, React, Automated PDF Watermark Engine
PROVEN CUSTOMER SUCCESS

Top-10 Contract Development and Manufacturing Organization (CDMO) (Illinois, USA)

The Challenge

Managing quality deviations across 3 manufacturing sites using hybrid paper binders led to average CAPA resolution times of 62 days and FDA 483 observations.

The Architectural Solution

Deployed Cognic Pharma eQMS software with structured root-cause investigation tools, automated SOP training interlocks, and digital audit defense portals.

Verified Operational Results
Reduced average CAPA investigation cycle time from 62 days to 19 days
Decreased repeat cleanroom particulate deviations by 68% in the first year
Successfully passed two consecutive FDA cGMP audits with zero critical observations
FREQUENTLY ASKED QUESTIONS

Technical & Regulatory Insights

Key architectural, compliance, and deployment details about our Quality Management System software platform.

What is a pharmaceutical eQMS?
A pharmaceutical electronic Quality Management System (eQMS) digitizes quality assurance processes in compliance with cGMP, FDA 21 CFR Part 11, and ISO standards. It manages deviations, corrective and preventive actions (CAPA), change controls, and controlled SOP documentation.
How does the eQMS support root-cause investigations?
The software embeds established quality investigation frameworks—including the 5-Whys, Ishikawa fishbone diagrams, and Failure Modes and Effects Analysis (FMEA)—guiding quality teams to identify true systemic root causes rather than superficial symptoms.
What is CAPA effectiveness verification?
Effectiveness verification is a mandatory quality step that evaluates whether an implemented CAPA actually solved the underlying problem. The software schedules follow-up audits and monitors manufacturing data to confirm the defect has not recurred.
How does the system enforce training before SOP changes take effect?
The system links document control with employee training. When an SOP is revised, the new version remains in a pending state until assigned manufacturing personnel complete their read-and-understood training, preventing untrained execution.
Is the software fully compliant with FDA 21 CFR Part 11?
Yes. The software provides validated electronic signatures, password authentication, session timeouts, and immutable cryptographic audit trails that record every creation, modification, and deletion event.

Ready to Transform Your Life Sciences Operations?

Speak with Cognic Systems principal pharmaceutical software architects to discuss GxP validation, clinical AI pipelines, and manufacturing execution systems.